Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teus van Laar

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Journal of Parkinson'S Disease|November 6, 2019
Introduction: The Gut-Brain Axis in Parkinson's DiseaseTeus van Laar
CNS Drugs|May 20, 2003
Levodopa-induced response fluctuations in patients with Parkinson's disease: strategies for managementTeus van Laar
Parkinsonism & Related Disorders|December 22, 2016
The need for non-oral therapy in Parkinson's disease; a potential role for apomorphineTeus van Laar, Robbert Borgemeester
Nederlands Tijdschrift Voor Geneeskunde|August 7, 2019
[Parkinson's disease as a neuropsychiatric disorder]Iris E Sommer, Teus van Laar
Nederlands Tijdschrift Voor Geneeskunde|November 19, 2010
[Treatment of drooling in patients with parkinsonism]Marieke van Onna, Teus van Laar
Journal of Parkinson'S Disease|May 24, 2024
The Effectiveness of Inpatient Rehabilitation in Parkinson's Disease: A Systematic Review of Recent StudiesElien Steendam-Oldekamp, Teus van Laar
Parkinsonism & Related Disorders|October 17, 2017
Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: A retrospective long-term follow-up studyRobbert W K Borgemeester, Teus van Laar
Parkinsonism & Related Disorders|May 6, 2019
Retinal layers in Parkinson's disease: A meta-analysis of spectral-domain optical coherence tomography studiesAsterios Chrysou, Nomdo M Jansonius, Teus van Laar
Parkinsonism & Related Disorders|December 10, 2016
Unmet needs in Parkinson's disease: New horizons in a changing landscapeK Ray Chaudhuri, Roongroj Bhidayasiri, Teus van Laar
BMC Neurology|June 5, 2024
Comment on "Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries"Harmen R Moes, Erik Buskens, Teus van Laar
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Journal of Parkinson'S Disease|November 6, 2019
Introduction: The Gut-Brain Axis in Parkinson's DiseaseTeus van Laar
CNS Drugs|May 20, 2003
Levodopa-induced response fluctuations in patients with Parkinson's disease: strategies for managementTeus van Laar
Parkinsonism & Related Disorders|December 22, 2016
The need for non-oral therapy in Parkinson's disease; a potential role for apomorphineTeus van Laar, Robbert Borgemeester
Nederlands Tijdschrift Voor Geneeskunde|August 7, 2019
[Parkinson's disease as a neuropsychiatric disorder]Iris E Sommer, Teus van Laar
Nederlands Tijdschrift Voor Geneeskunde|November 19, 2010
[Treatment of drooling in patients with parkinsonism]Marieke van Onna, Teus van Laar
Journal of Parkinson'S Disease|May 24, 2024
The Effectiveness of Inpatient Rehabilitation in Parkinson's Disease: A Systematic Review of Recent StudiesElien Steendam-Oldekamp, Teus van Laar
Parkinsonism & Related Disorders|October 17, 2017
Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: A retrospective long-term follow-up studyRobbert W K Borgemeester, Teus van Laar
Parkinsonism & Related Disorders|May 6, 2019
Retinal layers in Parkinson's disease: A meta-analysis of spectral-domain optical coherence tomography studiesAsterios Chrysou, Nomdo M Jansonius, Teus van Laar
Parkinsonism & Related Disorders|December 10, 2016
Unmet needs in Parkinson's disease: New horizons in a changing landscapeK Ray Chaudhuri, Roongroj Bhidayasiri, Teus van Laar
BMC Neurology|June 5, 2024
Comment on "Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries"Harmen R Moes, Erik Buskens, Teus van Laar
Pageof 16